Skip to main content

Want a detailed portfolio tracker?

Scinai Immunotherapeutics (SCNI) P/E (2023 - 2026)

Scinai Immunotherapeutics (SCNI) P/E from Mar 31, 2023 to Jul 21, 2026. The TTM Scinai Immunotherapeutics (SCNI) P/E is -0.23. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Scinai Immunotherapeutics (SCNI)

YearP/EChange
2026-0.23-65.51%
2025-0.67-78.71%
2024-3.13-43.82%
2023-5.57N/A

Comparison Scinai Immunotherapeutics (SCNI) P/E with competitors

Scinai Immunotherapeutics (SCNI) P/E is -0.23.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.74%
NBYStablecoin Development Corp0.00-101.87%
ENLVEnlivex Ltd0.07-132.55%
FGENFibroGen Inc0.24-204.46%
CHRSCoherus Biosciences Inc0.85-469.25%
FBIOFortress Biotech Inc0.95-512.98%
ORMPOramed Pharmaceuticals Inc1.50-754.07%
AGENAgenus Inc3.01-1409.67%
INVAInnoviva Inc3.15-1472.51%
VXRTVaxart Inc3.55-1644.71%
CRMDCorMedix Inc3.63-1678.96%
CVACCureVac N.V.4.45-2034.59%
GLPGGalapagos NV4.86-2214.40%
SRPTSarepta Therapeutics Inc4.88-2224.50%
ABEOAbeona Therapeutics Inc5.39-2444.44%
ABUSArbutus Biopharma Corp5.60-2535.00%
ZVRAZevra Therapeutics Inc5.89-2661.90%
SPROSpero Therapeutics Inc6.23-2810.38%
CGENCompugen Ltd6.31-2847.59%
RIGLRigel Pharmaceuticals6.87-3090.46%
SLXNSilexion Therapeutics Corp7.30-3274.98%
OMEROmeros Corporation9.26-4129.06%
AUPHAurinia Pharmaceuticals Inc9.58-4271.02%
PLXProtalix BioTherapeutics Inc10.89-4839.36%
ACADAcadia Pharmaceuticals Inc11.73-5203.82%
TBPHTheravance Biopharma Inc12.26-5436.03%
ADMAAdma Biologics Inc12.42-5503.92%
HRMYHarmony Biosciences Holdings Inc13.82-6114.04%
SABSSAB Biotherapeutics Inc14.14-6251.56%
NAGENiagen Bioscience Inc14.82-6548.31%
INCYIncyte Corp15.82-6985.40%
REGNRegeneron Pharmaceuticals Inc15.86-7000.24%
PBYIPuma Biotechnology Inc17.32-7635.17%
CPRXCatalyst Pharmaceuticals Inc17.44-7688.96%
EXELExelixis Inc17.54-7731.91%
TGTXTG Therapeutics Inc18.97-8353.34%
MDXGMimedx Group Inc20.55-9043.71%
XOMAXOMA Royalty Corp22.87-10054.50%
ARGXArgen X SE24.30-10673.89%
CTMXCytomX Therapeutics Inc24.82-10901.53%
XOMAOXOMA Royalty Corp25.34-11129.44%
HALOHalozyme Therapeutics Inc25.62-11250.81%
XOMAPXOMA Royalty Corp25.67-11271.00%
VRTXVertex Pharmaceuticals Inc27.99-12282.62%
RPRXRoyalty Pharma plc - Class A28.69-12584.11%
SLNOSoleno Therapeutics Inc29.02-12726.76%
ASNDAscendis Pharma A/S30.09-13192.49%
LGNDLigand Pharmaceuticals Inc - Class B37.91-16598.38%
APLSApellis Pharmaceuticals Inc39.02-17081.08%
BMRNBiomarin Pharmaceutical Inc42.21-18469.56%
KRYSKrystal Biotech Inc45.34-19832.37%
ONCBeiGene Ltd69.54-30362.30%
PHARPharming Group N.V.75.03-32749.31%
TECHBio-Techne Corp101.96-44469.81%
VCELVericel Corp109.92-47935.09%
ALNYAlnylam Pharmaceuticals Inc117.96-51435.54%
GMABGenmab140.29-61151.13%
TLXTelix Pharmaceuticals Ltd162.15-70664.97%
CORTCorcept Therapeutics Inc212.86-92730.42%